Under Proposed Purdue Pharma Opioid Settlement, Sacklers Would Still Be Billionaires

México Noticias Noticias

Under Proposed Purdue Pharma Opioid Settlement, Sacklers Would Still Be Billionaires
México Últimas Noticias,México Titulares
  • 📰 Forbes
  • ⏱ Reading Time:
  • 52 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 53%

Under the proposed Purdue Pharma opioid settlement, the Sacklers would still be billionaires by KristinStoller

A sign with the Sackler name is displayed at the Metropolitan Museum of Art in New York, Thursday, Jan. 17, 2019. The Sackler name adorns walls at some of the world's top museums and universities, including the Met, the Guggenheim and Harvard.

The owners of Purdue Pharma will keep their billionaire status even if they agree to a reported $10 to $12 billion settlement of thousands of lawsuits filed against the company,If the Sackler family, which owns Purdue Pharma, accepts the terms of a settlement now under discussion,estimates they will still be worth between $1 billion and $2 billion, down from a current net worth estimate of $11.2 billion.

Purdue said in a statement: “While Purdue Pharma is prepared to defend itself vigorously in the opioid litigation, the company has made clear that it sees little good coming from years of wasteful litigation and appeals. The people and communities affected by the opioid crisis need help now. Purdue believes a constructive global resolution is the best path forward, and the company is actively working with the state attorneys general and other plaintiffs to achieve this outcome.

As part of the settlement, the Sackler’s would be required to pay $3 billion of their own money, according to a

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Forbes /  🏆 394. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Purdue Pharma offers $10-12 billion to settle opioid claimsPurdue Pharma offers $10-12 billion to settle opioid claimsPurdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10B to $12B, according to 2 people familiar with the mediation.
Leer más »

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid claims: sourcesPurdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid claims: sourcesOxyContin maker Purdue Pharma and its owners, the Sackler family, is in discussi...
Leer más »

Report: Purdue Pharma Offered $10-12 Billion To Settle Thousands Of Opioid LawsuitsReport: Purdue Pharma Offered $10-12 Billion To Settle Thousands Of Opioid LawsuitsThe Sackler family is facing increasing blame for fueling the opioid crisis.
Leer más »

Purdue Pharma offers $10-12B to settle 2,000+ opioid lawsuitsPurdue Pharma offers $10-12B to settle 2,000+ opioid lawsuitsPurdue Pharma and its owners, the Sackler family, are offering to settle more than 2,000 lawsuits against the company for $10B to $12B, according to 2 people familiar with the mediation.
Leer más »

Purdue Pharma Offers Massive Settlement for Role in Opioid CrisisPurdue Pharma Offers Massive Settlement for Role in Opioid CrisisThe Sackler family will reportedly give up their ownership of the company as part of the $10-12 billion settlement.
Leer más »

Purdue Pharma in Talks to Resolve Opioid Cases Through BankruptcyPurdue Pharma in Talks to Resolve Opioid Cases Through BankruptcyOxyContin maker Purdue Pharma and its owners, the Sackler family, are in talks with state and local governments to resolve more than 2,000 opioid cases in a deal valued at between $10 billion and $12 billion.
Leer más »



Render Time: 2025-04-02 13:32:19